These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 10538088

  • 1. The drug formulary decision-making process.
    Brehany J, Cohen P, Sax MJ.
    Healthplan; 1999; 40(3):85-92. PubMed ID: 10538088
    [No Abstract] [Full Text] [Related]

  • 2. The case for a value-based formulary: striving for total lowest net cost.
    Weart W, Bauman GR.
    Manag Care Interface; 2007 Apr; 20(4):42-7. PubMed ID: 17474330
    [Abstract] [Full Text] [Related]

  • 3. Formulary submission process catches on ... slowly.
    Cross M.
    Manag Care; 2002 Nov; 11(11):32-6. PubMed ID: 12491856
    [No Abstract] [Full Text] [Related]

  • 4. Raising the bar in the formulary decision process.
    Navarro RP.
    Manag Care Interface; 1999 Jul; 12(7):51, 54. PubMed ID: 10539501
    [No Abstract] [Full Text] [Related]

  • 5. The Academy of Managed Care Pharmacy's format for formulary submission.
    Penna P.
    Manag Care Interface; 2001 Jun; 14(6):61-2. PubMed ID: 11432152
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The economics of lipid management.
    Mullins CD.
    Manag Care; 2001 Nov; 10(11 Suppl):17-8; discussion 19-24. PubMed ID: 11761626
    [No Abstract] [Full Text] [Related]

  • 8. Application of pharmacoeconomics to formulary decision making in managed care organizations.
    Suh DC, Okpara IR, Agnese WB, Toscani M.
    Am J Manag Care; 2002 Feb; 8(2):161-9. PubMed ID: 11858228
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Increasing stakes and complex dynamics in the formulary process.
    Tadlock C.
    Manag Care Interface; 2007 Mar; 20(3):12, 14. PubMed ID: 17458473
    [No Abstract] [Full Text] [Related]

  • 11. Managed care guidelines for the economic evaluation of pharmaceuticals.
    Langley PC, Martin RE.
    Am J Manag Care; 1997 Jul; 3(7):1013-21. PubMed ID: 10173366
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Do P&T committees have enough power? Plans and PBMs are divided about sharing drug prices with clinicians. Is it better to have an administrative committee determine the formulary?
    Cross M.
    Manag Care; 2007 Apr; 16(4):39-42. PubMed ID: 17491288
    [No Abstract] [Full Text] [Related]

  • 15. Formulary decision-making considerations: COX-2 inhibitors.
    Shaya FT, Wong W, Shin JY, Martin L, Samant N.
    Manag Care Interface; 2004 Nov; 17(11):29-36, 41. PubMed ID: 15573802
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Operation, formulary decision-making activities of a P & T Committee in a managed care setting.
    Adams J, Richardson J.
    Hosp Formul; 1991 Apr; 26(4):291-4, 300-1. PubMed ID: 10109798
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.